Chemoinformaics analysis of 4H-1-Benzopyran-4-one, 2-(3-furanyl)-
Molecular Weight | 212.204 | nRot | 1 |
Heavy Atom Molecular Weight | 204.14 | nRig | 1 |
Exact Molecular Weight | 212.047 | nRing | 3 |
Solubility: LogS | 0.678 | nHRing | 2 |
Solubility: LogP | -0.149 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 15 |
No. of Oxygen atom | 3 | No. of Arom Bond | 16 |
nHA | 3 | APOL | 29.4503 |
nHD | 0 | BPOL | 12.3657 |
QED | 0.577 |
Synth | 2.594 |
Natural Product Likeliness | 1.182 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.006 |
HIA | 0.01 |
CACO-2 | -4.416 |
MDCK | 0.0000248 |
BBB | 0.797 |
PPB | 0.21341 |
VDSS | 0.575 |
FU | 0.837931 |
CYP1A2-inh | 0.027 |
CYP1A2-sub | 0.353 |
CYP2c19-inh | 0.037 |
CYP2c19-sub | 0.819 |
CYP2c9-inh | 0.015 |
CYP2c9-sub | 0.829 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.622 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.188 |
CL | 8.106 |
T12 | 0.748 |
hERG | 0.021 |
Ames | 0.006 |
ROA | 0.008 |
SkinSen | 0.241 |
Carcinogencity | 0.069 |
EI | 0.988 |
Respiratory | 0.005 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.695136 |